Mark Currie
Login to view DISC.Dr. Mark Currie is a distinguished pharmaceutical leader and Venture Partner at Iaso Ventures, holding board positions at Sea Pharmaceuticals and Ironwood Pharmaceuticals. With a Ph. D. from Wake Forest University, his career is marked by senior R&D roles where he guided the development of novel therapies from discovery to market.
Outside of his primary professional focus, Mark has expressed a keen interest in environmental science, particularly in advancing the scientific understanding of coastal waters. He actively follows and encourages the work of teams dedicated to marine and coastal research, highlighting a passion that bridges science and nature.
His pioneering academic research on the guanylate cyclase-C (GC-C) pathway laid the foundation for the discovery of the blockbuster drug linaclotide (LINZESS).
Read the full overview →How Mark shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Mark cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.